Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Anatomic Stage IV Breast Cancer AJCC v8 · Metastatic Malignant Neoplasm in the Brain · Metastatic Triple-Negative Breast Carcinoma · Prognostic Stage IV Breast Cancer AJCC v8

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Moffitt Cancer Center, Tampa, Florida, United States
Roswell Park Cancer Institute, Buffalo, New York, United States
Contact: Study coordinator (Sheheryar Kabraji, BMBCh) · Sheheryar.Kabraji@roswellpark.org · 716-845-1486
Contact: Principal Investigator (Sheheryar Kabraji)
University of Virginia Comprehensive Cancer Center, Charlottesville, Virginia, United States
Contact: Study coordinator (Patrick Dillon, MD) · PMD5B@uvahealth.org · 434-924-8073
Contact: Principal Investigator (Patrick Dillon, MD)

Study leads

Sheheryar Kabraji, BMBCh
Principal Investigator
Roswell Park Cancer Institute

View source on ClinicalTrials.gov